These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7979552)

  • 1. Elevated levels of soluble tumour necrosis factor receptor I in blister fluids of bullous pemphigoid and suction blisters.
    Zentner A; Rendl J; Grelle I; Dummer R; Bröcker EB; Zillikens D
    Arch Dermatol Res; 1994; 286(6):355-7. PubMed ID: 7979552
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of tumor necrosis factor in blister fluids of bullous pemphigoid.
    Takematsu H; Ohta H; Tagami H
    Arch Dermatol Res; 1991; 283(2):131-2. PubMed ID: 2069411
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of IL-1 alpha, IL-1 beta and IL-1 receptor antagonist in blister fluid of bullous pemphigoid.
    Schmidt E; Mittnacht A; Schömig H; Dummer R; Bröcker EB; Zillikens D
    J Dermatol Sci; 1996 Feb; 11(2):142-7. PubMed ID: 8869035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of interleukin-8 in blister fluid of bullous pemphigoid compared with suction blisters of healthy control subjects.
    Schmidt E; Ambach A; Bastian B; Bröcker EB; Zillikens D
    J Am Acad Dermatol; 1996 Feb; 34(2 Pt 1):310-2. PubMed ID: 8642104
    [No Abstract]   [Full Text] [Related]  

  • 5. The existence of a platelet-activating factor (Paf-acether)-like substance in blister fluid derived from patients with bullous pemphigoid as demonstrated by human platelet aggregation techniques.
    Okubo K; Karashima T; Hachisuka H; Sasai Y
    Kurume Med J; 1989; 36(4):173-9. PubMed ID: 2700767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blister fluid cytokines in cutaneous inflammatory bullous disorders.
    Rhodes LE; Hashim IA; McLaughlin PJ; Friedmann PS
    Acta Derm Venereol; 1999 Jul; 79(4):288-90. PubMed ID: 10429986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of interleukin-8, soluble CD4 and soluble CD8 in bullous pemphigoid blister fluid. The relationship between local cytokine production and lesional T-cell activities.
    Sun CC; Wu J; Wong TT; Wang LF; Chuan MT
    Br J Dermatol; 2000 Dec; 143(6):1235-40. PubMed ID: 11122027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The autoimmune blistering skin disease bullous pemphigoid. The presence of plasmin/alpha 2-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin.
    Kramer MD; Reinartz J
    J Clin Invest; 1993 Aug; 92(2):978-83. PubMed ID: 7688770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between theoretical molecular weight and blister fluid/serum ratio of cytokines and five other molecules evaluated in patients with bullous pemphigoid.
    D'Auria L; Pimpinelli F; Ferraro C; D'Ambrogio G; Giacalone B; Bellocci M; Ameglio F
    J Biol Regul Homeost Agents; 1998; 12(3):76-80. PubMed ID: 9795835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid.
    Schmidt E; Bastian B; Dummer R; Tony HP; Bröcker EB; Zillikens D
    Arch Dermatol Res; 1996 Jun; 288(7):353-7. PubMed ID: 8818181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of eotaxin and interleukin-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia.
    Wakugawa M; Nakamura K; Hino H; Toyama K; Hattori N; Okochi H; Yamada H; Hirai K; Tamaki K; Furue M
    Br J Dermatol; 2000 Jul; 143(1):112-6. PubMed ID: 10886144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interleukin-2 receptor in lesions and serum of bullous pemphigoid.
    Zillikens D; Ambach A; Schuessler M; Dummer R; Hartmann AA; Burg G
    Arch Dermatol Res; 1992; 284(3):141-5. PubMed ID: 1503497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
    Verraes S; Hornebeck W; Polette M; Borradori L; Bernard P
    J Invest Dermatol; 2001 Nov; 117(5):1091-6. PubMed ID: 11710917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil-colony stimulating activity in blister fluid of bullous pemphigoid.
    Kawachi Y; Otsuka F
    J Dermatol Sci; 1997 May; 15(1):51-4. PubMed ID: 9186812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid.
    Kakinuma T; Wakugawa M; Nakamura K; Hino H; Matsushima K; Tamaki K
    Br J Dermatol; 2003 Feb; 148(2):203-10. PubMed ID: 12588369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells.
    Teraki Y; Hotta T; Shiohara T
    J Invest Dermatol; 2001 Nov; 117(5):1097-102. PubMed ID: 11710918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased immunoreactive interleukin-5 levels in blister fluids of bullous pemphigoid.
    Endo H; Iwamoto I; Fujita M; Okamoto S; Yoshida S
    Arch Dermatol Res; 1992; 284(5):312-4. PubMed ID: 1444583
    [No Abstract]   [Full Text] [Related]  

  • 18. [Leukotriene (LT) B4 and LTC4 in the blister fluid of bullous pemphigoid].
    Kawana S; Nishiyama S
    Nihon Hifuka Gakkai Zasshi; 1989 May; 99(6):659-64. PubMed ID: 2555604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of collagenase and elastase activities in the blister fluids from bullous skin diseases. Comparison between dermatitis herpetiformis and bullous pemphigoid.
    Oikarinen AI; Zone JJ; Ahmed AR; Kiistala U; Uitto J
    J Invest Dermatol; 1983 Sep; 81(3):261-6. PubMed ID: 6309988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased CCL1 levels in the sera and blister fluid of patients with bullous pemphigoid.
    Miyagaki T; Sugaya M; Kagami S; Nakashima H; Ishiura N; Watanabe R; Ohmatsu H; Fujita H; Yazawa N; Kadono T; Fujimoto M; Saeki H; Tamaki K
    J Dermatol Sci; 2009 Apr; 54(1):45-7. PubMed ID: 19117730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.